These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches. Shitaye G, Gadisa E, Grignard L, Shumie G, Chali W, Menberu T, Belachew M, Tegegn G, Challi S, Curry J, Mahey L, Hailu T, Mamo H, Menon M, Balcha T, Aseffa A, Drakeley C, Bousema T, Tadesse FG. Malar J; 2018 Aug 02; 17(1):281. PubMed ID: 30071859 [Abstract] [Full Text] [Related]
8. Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan. Ali Albsheer MM, Lover AA, Eltom SB, Omereltinai L, Mohamed N, Muneer MS, Mohamad AO, Abdel Hamid MM. PLoS Negl Trop Dis; 2021 Oct 02; 15(10):e0009720. PubMed ID: 34699526 [Abstract] [Full Text] [Related]
15. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. Devine A, Battle KE, Meagher N, Howes RE, Dini S, Gething PW, Simpson JA, Price RN, Lubell Y. PLoS Med; 2021 Jun 02; 18(6):e1003614. PubMed ID: 34061843 [Abstract] [Full Text] [Related]
19. Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK). Lee W, Lee SE, Lee MJ, Noh KT. Malar J; 2020 Sep 01; 19(1):317. PubMed ID: 32873296 [Abstract] [Full Text] [Related]
20. Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals. Lover AA, Dantzer E, Hongvanthong B, Chindavongsa K, Welty S, Reza T, Khim N, Menard D, Bennett A. Malar J; 2018 Jun 01; 17(1):218. PubMed ID: 29859089 [Abstract] [Full Text] [Related] Page: [Next] [New Search]